... of disease by conventional means, i.e. with drugs
having effects opposite to the symptoms. Often ... to the practice of treating diseases by means of drugs
inducing symptoms unrelated (i.e. neither similar ... the practice of treating diseases by means of drugs
producing symptoms opposite to those of the ...
... has developed from herbalism and many drugs
are still derived from plants (atropine, ... The medical establishment is now developing drugs
targeted towards one particular disease process. Thus drugs
are being developed to minimise the side effects ...
... Famous psychiatrists
... starting with the efficacy of neuroleptic drugs
in attenuating symptoms (Shapiro, Shapiro and ...
Depolarization-induced suppression of inhibition
... mediators of DSI. They showed that cannabinoid receptor agonists, drugs
that mimic the actions of endocannabinoids or THC, could evoke the same ... that DSI could be prevented by cannabinoid receptor antagonists , drugs
that block the actions of cannabinoid compounds.
Other lines of evidence ...
... emerged over the past decade.
Many established branded blockbuster drugs
are coming, or have already, come to the end of their patent-protected ... blockbuster drugs, such as Lipitor, compare favorably with cheaper generic drugs
only in a small percentage of patients. But since it is not known how to ...
... in such a way that someone not familiar with the data can immediately understand the meaning of the data. With an increasing demand for getting new drugs
to the market as quickly as possible, writing documents that can be read and understood quickly and easily has become an ever higher priority. Hence, ...
... mumijo has antiseptic and stimulant properties, so it tends to increase wound healing rate and produce better results. Two commercial mumijo-based drugs
were developed and at least three conference on post-operational application of mumijo were held.
Mumijo should not be confused with balsams and ...